Our assessment
NexLife publishes a detailed plan ladder: four commitment lengths for each of two drugs, each with the saving printed beside it, on pages you can read without an intake. It states that the price doesn't change with the dose and that no membership or contract applies. Then its tirzepatide page quotes a starting figure for semaglutide that matches none of the four figures on the semaglutide page — whose own FAQ gives a third. Three floors, one drug. The company also received an FDA warning letter in June 2026 over how it described these products.
The ladder is the best thing here
Both drugs get their own page, and both pages publish the same structure: a one-month rate with no commitment, then three prepaid terms, each with its own per-month figure and the saving stated beside it. Nothing is behind a quiz.
The pages also answer the question the ladder raises. The FAQ on each restates every rung in a sentence, so the grid and the prose agree — which sounds trivial until you notice how many sellers here publish a grid and then quote a different number in their own copy.
Both pages state that the price is the same at every dose and that there are no memberships or contracts, and the footer adds that medication costs are included in the selected program unless stated otherwise. One hundred and twenty-nine of the four hundred and twenty sellers here charge no membership.
Three starting figures for one drug
Here is the problem, and it is entirely internal to the site. The semaglutide plan page bottoms out at its twelve-month rate. The FAQ on that same page says the drug starts at a higher figure — the one-month rate — which is a defensible way to describe a floor.
The tirzepatide page then carries a sentence comparing the two drugs, and inside it quotes a semaglutide starting figure that is neither of those. It matches no rung on the ladder.
None of the three is hidden and none is enormous. But land on the tirzepatide page, take the comparison sentence at face value, and you will reach checkout expecting a number NexLife doesn't offer. Compare on the four published rungs.
The FDA letter, and what it does and does not say
The agency reviewed this site in March 2026 and wrote in June. The letter names the domain and a federal establishment identifier, and finds that the site's claims about its compounded semaglutide and tirzepatide products were false or misleading, which makes those products misbranded under two sections of the statute.
A warning letter is a disclosure, not a finding of guilt. Eighty of the four hundred and twenty sellers here carry one. The agency publishes the letter itself, with its number and its date.
One narrow fact about today's pages: the claim shape the agency cites most often across this field — that a compounded preparation contains the same active ingredient as a named brand drug — does not appear on the semaglutide plan page. That is one page on one date, and nothing published says the matter is resolved.
Credentials in place of names
Ask who fills the prescription and you get a list of qualifications: US-licensed 503A compounding pharmacies, FDA-registered 503B outsourcing facilities, and partners that may hold a certification, an accreditation, state board licensure or a federal registration. Every one of those is a category. Three hundred and twenty-six of the four hundred and twenty sellers here name no compounding pharmacy at all.
Ask who prescribes and you get a care team of board-certified physicians, registered dietitians and care coordinators. No individual is named. Three hundred of the four hundred and twenty sellers here name nobody.
Ask where it operates and you get two words: licensed nationwide. That names no state and excludes none, and no page publishes a list. Two hundred and eighty-six of the four hundred and twenty sellers here publish no service area at all.
What the site does publish about quality is specific and checkable in principle: every batch independently tested for potency, sterility, pH and endotoxin levels, and pharmacies holding a named certification. That is a stronger claim than most of this field makes, and it would be stronger still with a pharmacy attached to it.
What the program actually includes
The plans are itemized rather than gestured at: free expedited shipping, provider consultations, a personalized nutrition plan and a coaching call, each with a stated dollar value, adding to a total the site prints as included at no extra cost.
There is also a money-back warranty in the FAQ, conditioned on following the plan and on a stated percentage of body weight over six months. Read the condition. A guarantee with a compliance requirement attached is a different product from one without.
And read the term. Every figure below the one-month rate requires paying for three, six or twelve months in a single charge. NexLife prints the saving in dollars beside each, which is the honest way to present it, but the money leaves at the start either way.
NexLife's published pricing
Prices re-verified September 2026
| Medication | Price |
|---|---|
| MedicationSemaglutide (compounded) — same price at every dose, stated on the page | Price$139/mo$139 a month on the no-commitment one-month plan, all-inclusive, same price at every dose, no memberships or contracts |
| MedicationSemaglutide (compounded) — same price at every dose, three-month plan | Price$132/mo$132 a month on the three-month plan, a $48 savings over the one-month rate |
| MedicationSemaglutide (compounded) — same price at every dose, six-month plan | Price$125/mo$125 a month on the six-month plan, a $108 savings over the one-month rate |
| MedicationSemaglutide (compounded) — same price at every dose, twelve-month plan | Price$119/mo$119 a month on the twelve-month plan, the lowest published rate — though the seller's tirzepatide page separately lists semaglutide from $135 a month |
| MedicationTirzepatide (compounded) — same price at every dose, one-month plan | Price$169/mo$169 a month on the no-commitment one-month plan, all-inclusive with no membership fees |
| MedicationTirzepatide (compounded) — same price at every dose, three-month plan | Price$159/mo$159 a month on the three-month plan, a $30 savings over the one-month rate |
| MedicationTirzepatide (compounded) — same price at every dose, six-month plan | Price$149/mo$149 a month on the six-month plan, a $120 savings over the one-month rate |
| MedicationTirzepatide (compounded) — same price at every dose, twelve-month plan | Price$139/mo$139 a month on the twelve-month plan, the lowest published tirzepatide rate, a $360 savings |
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
See NexLife's current price →Who NexLife suits
Good fit if
- Readers who want every commitment length priced in one place, for both drugs, without an intake.
- Buyers who want the saving stated in dollars beside each rung rather than as a percentage.
- People who want the price stated as flat across doses, on the page rather than in a footnote.
- Anyone who wants a stated absence of membership and contracts rather than silence.
- Readers who value a published batch-testing standard, even without a pharmacy name attached to it.
Look elsewhere if
- Anyone comparing on a starting figure. This site quotes three different floors for compounded semaglutide across two of its own pages.
- Readers for whom an FDA warning letter about product claims is a filter.
- Buyers who want the compounding pharmacy named. The disclosures here are credential categories.
- Anyone who wants their state confirmed. Licensed nationwide is the whole of the coverage disclosure.
- People unwilling to prepay. Every rung below the one-month rate is a three-, six- or twelve-month charge.
What stands out about NexLife
Strengths
- Publishes four commitment lengths for both drugs with the saving stated beside each, which is the fullest plan ladder in this batch
- States that the price does not change with the dose, on both priced pages
- States that no membership or contract applies and that medication costs are inside the program price
- Describes what the plan includes as itemised deliverables — nutrition plan, coaching call, provider review — with a stated dollar value against each
- States that every batch is independently tested for potency, sterility, pH and endotoxin levels
Trade-offs
- Received an FDA warning letter (No. 730096, issued 8 June 2026) over false or misleading claims about its compounded semaglutide and tirzepatide products, citing a March 2026 review of the site
- Publishes three different starting figures for compounded semaglutide across two of its own pages in one reading — $119, $139 and $135
- Names no compounding pharmacy and no individual clinician; the disclosures are credential categories
- Publishes no list of states served; "Licensed nationwide" is the whole of it
- Every figure below the one-month rate requires a prepaid commitment of three months or more
How this review was verified
- Both plan pages, the privacy-choices page and the homepage read.
- Eight rungs are published in all — four commitment lengths for each drug — with the saving printed beside each.
- Each grid rung matches the FAQ sentence on the same page. The tirzepatide page's comparison sentence quotes a third semaglutide floor that matches no rung.
- The claim shape the FDA letter concerns does not appear on the priced pages on that date.
Where NexLife ranks
NexLife qualifies for 3 of the 6 boards on this site. A board only ranks the providers that meet its own condition, so a missing board means NexLife does not publish what that board sorts on.
- Semaglutide — #239 of 334
- Tirzepatide — #223 of 319
- Cheapest Overall — #272 of 396
Compare NexLife directly
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
| Provider | Score | From/mo | Full review | Action |
|---|---|---|---|---|
| Belle Health | 10.0/10 | From/mo$109Advertised monthly equivalent for a twelve-month supply; not a verified monthly installment. Six-month rate $119, two-month rate $135, one-month rate $199. Confirm the upfront payment and refill schedule. | Full reviewRead the Belle Health review | Visit |
| Midi Health | 10.0/10 | From/mo$164for a 4-week supply, the lowest of four published dose tiers, including shipping | Full reviewRead the Midi Health review | Visit |
| altRx | 8.6/10 | From/mo$89/moadvertised monthly starting price for a multi-dose vial; confirm plan length and checkout total | Full reviewRead the altRx review | Visit |
Frequently asked questions
What does compounded semaglutide actually start at here?
The site gives three answers. The plan grid bottoms out at the twelve-month rate, the same page's FAQ quotes the one-month rate as the starting figure, and a sentence on the tirzepatide page quotes a third number that matches no rung at all. Compare on the four published rungs.
Is there a membership fee?
No. Both priced pages say the price is the same at every dose with no memberships or contracts, the tirzepatide plan header says no membership fees, and the footer states that medication costs are included in the selected program unless otherwise stated.
What was the FDA warning letter about?
A review of this site in March 2026 found its claims about its compounded semaglutide and tirzepatide products false or misleading, which makes the products misbranded under the statute. The letter names the domain and a federal establishment identifier. The FDA publishes the number, the date and the full text.
Which pharmacy compounds the medication?
The site doesn't say. It lists the classes of pharmacy it may use and the credentials those pharmacies may hold, which is a category rather than a name. Three hundred and twenty-six of the four hundred and twenty sellers here name no compounding pharmacy at all.
Does it serve my state?
The site says licensed nationwide and nothing more. No page names a state or an exclusion. Two hundred and eighty-six of the four hundred and twenty sellers here publish no service area at all, so the silence is ordinary — and it still has to be confirmed before you plan around it.
Do I have to prepay?
For anything below the one-month rate, yes. The three-, six- and twelve-month rungs are single charges, and the site prints the dollar saving beside each. The one-month rate is the only figure here that doesn't require a commitment.
Ready to compare directly?
NexLife scores 2.9/10 on this site's rubric. Review the published prices and their conditions above, then confirm your total with the provider. Visiting its site does not commit you to treatment.
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
Visit NexLife →